Implementation of a national waterborne disease outbreak surveillance system: overview and preliminary results, France, 2010 to 2019.

EpiGEH health insurance data medicalised acute gastro-enteritis spatio-temporal clusters surveillance system waterborne disease outbreaks

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
08 2021
Historique:
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 14 9 2021
Statut: ppublish

Résumé

BackgroundWaterborne disease outbreaks (WBDO) associated with tap water consumption are probably underestimated in France.AimIn order to improve their detection, Santé publique France launched a surveillance system in 2019, based on the periodical analysis of health insurance data for medicalised acute gastroenteritis (mAGE).MethodsSpatio-temporal cluster detection methods were applied to mAGE cases to prioritise clusters for further investigation. These investigations determined the plausibility that infection is of waterborne origin and the strength of association.ResultsBetween January 2010 and December 2019, 3,323 priority clusters were detected (53,878 excess mAGE cases). They involved 3,717 drinking water supply zones (WSZ), 15.4% of all French WSZ. One third of these WSZ (33.4%; n = 1,242 WSZ) were linked to repeated clusters. Moreover, our system detected 79% of WBDO voluntarily notified to health authorities.ConclusionEnvironmental investigations of detected clusters are necessary to determine the plausibility that infection is of waterborne origin. Consequently, they contribute to identifying which WSZ are linked to clusters and for which specific actions are needed to avoid future outbreaks. The surveillance system incorporates three priority elements: linking environmental investigations with water safety plan management, promoting the systematic use of rainfall data to assess waterborne origin, and focusing on repeat clusters. In the absence of an alternative clear hypothesis, the occurrence of a mAGE cluster in a territory completely matching a distribution zone indicates a high plausibility of water origin.

Identifiants

pubmed: 34448447
doi: 10.2807/1560-7917.ES.2021.26.34.2001466
pmc: PMC8393890
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

MMWR Morb Mortal Wkly Rep. 2015 Aug 14;64(31):842-8
pubmed: 26270059
Int J Environ Res Public Health. 2020 Jun 16;17(12):
pubmed: 32560168
J Water Health. 2008 Dec;6(4):491-503
pubmed: 18401114
Epidemiol Infect. 1998 Aug;121(1):109-19
pubmed: 9747762
Int J Environ Res Public Health. 2018 Jul 17;15(7):
pubmed: 30018195
J Water Health. 2010 Mar;8(1):20-34
pubmed: 20009244
Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167
pubmed: 28756037
J Water Health. 2017 Aug;15(4):475-489
pubmed: 28771145
Epidemiol Infect. 2016 Feb;144(3):591-601
pubmed: 26194500
J Water Health. 2014 Dec;12(4):634-55
pubmed: 25473972
Euro Surveill. 2015 Jun 18;20(24):
pubmed: 26111239
PLoS Negl Trop Dis. 2017 Jun 12;11(6):e0005659
pubmed: 28604791
Water Res. 2009 May;43(8):2159-68
pubmed: 19303126
Epidemiol Infect. 2012 Apr;140(4):697-705
pubmed: 21676346
Epidemiol Infect. 2011 Sep;139(9):1388-95
pubmed: 21108871
PLoS Med. 2005 Mar;2(3):e59
pubmed: 15719066
Clin Microbiol Rev. 2010 Jul;23(3):507-28
pubmed: 20610821

Auteurs

Jerome Pouey (J)

Santé publique France, Saint-Maurice, France.

Catherine Galey (C)

Santé publique France, Saint-Maurice, France.

Julie Chesneau (J)

Santé publique France, Saint-Maurice, France.

Gabrielle Jones (G)

Santé publique France, Saint-Maurice, France.

Nathalie Franques (N)

Direction générale de la Santé, Ministère des solidarités et de la santé, Paris, France.

Pascal Beaudeau (P)

Santé publique France, Saint-Maurice, France.
Santé publique France, Saint-Maurice, France.

Damien Mouly (D)

Santé publique France, Saint-Maurice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH